Floatz logo

Therapeutic Asset Ratings

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Epirubicin
Progesterone-Receptor Negative Breast Cancer
Massachusetts General HospitalP2BB (66)
Fludarabine
B-Cell Non-Hodgkin Lymphoma
Swiss Cancer InstituteP2BB (66)
Fludarabine
Congenital Amegakaryocytic Thrombocytopenia
Fred Hutchinson Cancer CenterP2BB (66)
Fludarabine
Hematopoietic And Lymphoid System Neoplasm
National Cancer Institute (NCI)P2BB (66)
Fluorouracilum
Cancer Of Unknown Primary Site
Alliance for Clinical Trials in OncologyP2BB (66)
Imatinib
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
The University of Hong KongP2BB (66)
Irinotecan
Pancreatic Acinar Cell Carcinoma
Artios Pharma LtdP2BB (66)
Lenalidomide
MALT Lymphoma
Yazeed SawalhaP2BB (66)
Lenalidomide
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P2BB (66)
Melphalan
Graft Versus Host Disease
City of Hope Medical CenterP2BB (66)
Melphalan
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
City of Hope Medical CenterP2BB (66)
Methotrexate
Leukemia, Myeloid, Accelerated-Phase
University of Michigan Rogel Cancer CenterP2BB (66)
Methotrexate
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
University of Michigan Rogel Cancer CenterP2BB (66)
Mitoxantrone
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
Institut de Recherches Internationales ServierP2BB (66)
Mogamulizumab
Adult T-Cell Leukemia/Lymphoma
Memorial Sloan Kettering Cancer CenterP2BB (66)
Nivestim
Acute Biphenotypic Leukemia
Ossium Health, Inc.P2BB (66)
Nivestim
Mantle Cell Lymphoma
Fred Hutchinson Cancer CenterP2BB (66)
Nivestim
Neoplasm
Ankara Etlik City HospitalP2BB (66)
Obinutuzumab
B-Cell Non-Hodgkin Lymphoma
Brown UniversityP2BB (66)
Obinutuzumab
Richter Transformation
Christine RyanP2BB (66)
Olaparib
Malignant Pancreatic Neoplasm
MOMA TherapeuticsP2BB (66)
Pembrolizumab
Estrogen-Receptor Negative Breast Cancer
Massachusetts General HospitalP2BB (66)
Pembrolizumab
Primary Mediastinal Large B-Cell Lymphoma
Seda S. ToluP2BB (66)
Pembrolizumab
Progesterone-Receptor Negative Breast Cancer
Massachusetts General HospitalP2BB (66)
Pembrolizumab
Fallopian Tube Carcinoma
Roswell Park Cancer InstituteP2BB (66)
Showing 2401 to 2425 of 42,301 assets
PreviousPage 97 of 1693Next